Identification and Characterization of a Novel Class of c-Jun N-terminal Kinase Inhibitors
Molecular Pharmacology, 04/06/2012
Schepetkin IA et al. – Authors conclude that compounds with an indenoquinoxaline nucleus can serve as specific small–molecule modulators for mechanistic studies of JNKs, as well as a potential leads for the development of anti–inflammatory drugs.



